ALKERMES | ALKS - EPS Earnings Per Share


ALKERMES reported $0 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.01 0.49 Oct/28
FY2026Q2 Jun/2026 -0.02 0.52 Jul/28
FY2026Q1 Mar/2026 -0.40 -0.4 0.13 May/05
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
ALKERMES USD 0 0.4 Jun/2026
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Malin Corporation EUR -0.06 0.1 Dec/2023
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Otsuka Holdings JPY 222.76 36.45 Jun/2026
Ovoca Bio EUR 0 0.06 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026